Pictet Asset Management
IMNM icon

Pictet Asset Management’s Immunome IMNM Stock Holding History

Pictet Asset Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$310K Hold
14,619
– – ﹤0.01% 1755
2026
Q1 		$320K Hold
14,619
– – ﹤0.01% 1688
2025
Q4 		$314K Hold
14,619
– – ﹤0.01% 1685
2025
Q3 		$171K Buy
+14,619
New +$145K ﹤0.01% 1917
2025
Q2 		– Sell
-10,181
Closed -$68.5K – 2028
2025
Q1 		$68.5K Buy
+10,181
New +$97.7K ﹤0.01% 1975

Other funds holding IMNM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Pictet Asset Management's IMNM Position: Q2 2026 in Review

Pictet Asset Management held its Immunome (IMNM) position steady in Q2 2026 at 14,619 shares worth $310K. The position accounts for ﹤0.01% of the portfolio, ranked #1755.

Pictet Asset Management first reported a position in IMNM in Q1 2025 and has held it in 5 quarters since. The position peaked at $320K in Q1 2026. 62 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Pictet Asset Management held 14,619 shares of Immunome worth $310K as of Q2 2026.
  • Pictet Asset Management left its Immunome share count unchanged in Q2 2026.
  • Immunome made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1755 holding.
  • Pictet Asset Management first reported a position in Immunome in Q1 2025 and has held it in 5 quarters since.
  • Pictet Asset Management's Immunome position peaked at $320K in Q1 2026.
  • 62 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.